In what should come as no surprise to anyone who knows the effects of smoking on patients with asthma, a new report indicates that the latest strings of indoor smoking bans will have a direct impact on reducing emergency room visits due to asthma attacks. Basically, it proves that not subjecting children with breathing problems to tobacco smog is good for their health.
The study was done by researchers at the University of Chicago Medicine, Tech Times reports, and their findings indicate that the ban on smoking indoors results in the drastic reduction of asthma attacks among children that lead to emergency room visits. Three years after the ban was put in effect, ER visits were reduced by 17 percent.
Christina Ciaccio is an expert in pediatric allergy and along with her team, they looked into the emergency room records of over 20 cities where indoor smoking has been banned. After looking at their records from 2000 until 2014, the researchers noted a definite decrease in overall ER visits prompted by breathing problems among asthmatic patients.
This isn’t really surprising since air pollution of any kind has been a major hazard for the 6.3 million American children with asthma living in the U.S. alone. To be fair, other causes of asthma attacks can include everything from car exhaust, factory smoke, allergens, dust, and the occasional overexertion when the weather is cold.
However, as far as causes that induce attacks indoors go, smoking is cited as one of the leading factors, hence the ban. Then again, the researchers themselves acknowledge that their findings are not entirely foolproof since there are some fluctuations in data, MedicalXpress reports. For now, the results of the study simply show that the legislative action pertaining to the smoking ban has a significant impact on public health.


RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
CDC Confirms U.S. Ebola Case Linked to Congo Outbreak as Travel Restrictions Tighten
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Why the future of marijuana legalization remains hazy despite high public support 



